Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country

Edward Mezones-Holguin, Rocio Violeta Gamboa-Cardenas, Gadwyn Sanchez-Felix, José Chávez-Corrales, Luis Miguel Helguero-Santin, L Max Laban-Seminario, Paula Alejandra Burela-Prado, Maribel Marilu Castro-Reyes, Fabian Fiestas

Research output: Contribution to journalReview articlepeer-review

Original languageAmerican English
JournalFrontiers in Pharmacology
StatePublished - 8 Sep 2019

Cite this